Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$2.17M
76.75K shares
What this filing means
BERNSTEIN HAROLD plans to sell 76.75K shares of MAZE THERAPEUTICS, INC. valued at approximately $2.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006773
Officer· President, R&D & CMO
Since Mar 2026
76.75K
Shares to sell
$2.17M
Approx. market value
46.89K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/1/2026
46.89KTotal acquired46.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of Stock Options Cash | 46.89K | — |
| Total | 46.89K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
14.85K
Market value
$381.1K
6/1/2026
—Completed
Units to sell
15K
Market value
$393.4K
5/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
46.89K
Market value
$1.40M
7/1/2026
Total
Units
76.75K
Value
$2.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 14.85K | $381.1K | — | Completed |
5/14/2026 | 15K | $393.4K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 46.89K | $1.40M | NASDAQ | Planned |
| Total | 76.75K | $2.17M | ||